Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome".

Thumbnail
View/Open
Date
2016-06-01
ICR Author
Author
Spain, L
Larkin, J
Martin-Liberal, J
Type
Journal Article
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/589
DOI
Collections
Subject
Humans
Diabetes Mellitus
Antibodies, Monoclonal
Insulins
Research team
Melanoma and Kidney Cancer
Language
eng
Date accepted
2016-05-07
License start date
2016-06
Citation
Cancer immunology, immunotherapy : CII, 2016, 65 (6), pp. 769 - 770
Publisher
SPRINGER